Status:
NOT_YET_RECRUITING
Individual Risk Profiles for Adverse Drug Reactions in Geriatric Patients
Lead Sponsor:
RWTH Aachen University
Collaborating Sponsors:
B. Braun Foundation
Conditions:
Polypharmacy
Pharmacogenetics
Eligibility:
All Genders
70+ years
Brief Summary
This project will generate a prospective cohort of geriatric patients with polypharmacy which will be characterized for vulnerability profiles of adverse drug reactions.
Detailed Description
Adverse drug reactions are common in older patients and can lead to severe outcomes such as falls, hospitalizations and death. They are dose-dependent and may for example be caused by inappropriate do...
Eligibility Criteria
Inclusion
- 70 years or older
- Current drug therapy with three or more drugs
- Being a patient in the interdisciplinary polypharmacy consultation service of the geriatric university outpatient clinic
- Sufficient mobility (minimum: Wheelchair mobility)
- Written informed consent of the patient or the legal representative
Exclusion
- No sufficient communication possible
- Patients classified as terminally ill by the medical staff
- Patients, that are incapable to give their informed consent and who do not have a legal representative
Key Trial Info
Start Date :
July 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
February 1 2032
Estimated Enrollment :
2000 Patients enrolled
Trial Details
Trial ID
NCT05247814
Start Date
July 1 2022
End Date
February 1 2032
Last Update
June 23 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.